Lash TL et al. (2010). Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen. Acta Oncol.49 (3): 305-12. PMID20156115. DOI: 10.3109/02841860903575273.
drugs.com
X. The American Society of Health-System Pharmacists. Geraadpleegd op 28 december 2017.
Lash TL et al. (2010). Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen. Acta Oncol.49 (3): 305-12. PMID20156115. DOI: 10.3109/02841860903575273.